Rani Therapeutics

OverviewSuggest Edit

Rani Therapeutics, LLC develops a oral biotherapeutics technology for the oral delivery of large drug molecules, including peptides, proteins, and antibodies. The company is based in San Jose, California.
TypePrivate
Founded2012
HQSan Jose, CA, US
Websiteranitherapeutics.com

Latest Updates

Cybersecurity ratingBMore

Key People/Management at Rani Therapeutics

Mir Imran

Mir Imran

Founder and Chairman & CEO
Mir Hashim

Mir Hashim

Chief Scientific Officer, Director
Svai Sanford

Svai Sanford

Chief Financial Officer
Stephanie McGrory

Stephanie McGrory

Vice President, Business Development
Talat Imran

Talat Imran

Vice President, Strategy
Angela Murch

Angela Murch

Vice President, Intellectual Property
Show more

Rani Therapeutics Office Locations

Rani Therapeutics has an office in San Jose
San Jose, CA, US (HQ)
2051 Ringwood Ave
Show all (1)

Rani Therapeutics Financials and Metrics

Summary Metrics

Founding Date

2012

Rani Therapeutics total Funding

$176.5 m

Rani Therapeutics latest funding size

$69 m

Time since last funding

3 months ago

Rani Therapeutics investors

Rani Therapeutics's latest funding round in December 2020 was reported to be $69 m. In total, Rani Therapeutics has raised $176.5 m
Show all financial metrics

Rani Therapeutics Cybersecurity Score

Cybersecurity ratingPremium dataset

B

89/100

SecurityScorecard logo

Rani Therapeutics Online and Social Media Presence

Embed Graph

Rani Therapeutics News and Updates

Rani Therapeutics Raises $69 Million Series E To Advance Clinical Trials And Manufacturing Of Robotic Pill

SAN JOSE, Calif., Dec. 10, 2020 /PRNewswire/ -- Rani Therapeutics, a clinical-stage biopharmaceutical company and developer of the RaniPill™ robotic pill, today announced that it has raised $69 million in a Series E financing, bringing the total funding to $211 million. BofA Securities...

Rani Therapeutics Hires First CFO

SAN JOSE, Calif., May 10, 2019 /PRNewswire/ -- Rani Therapeutics, creator of the robotic RaniPill™ capsule designed to replace injections of large drug molecules including peptides, proteins, and antibodies, today announced that Svai Sanford has joined the company as its first Chief...

Rani Therapeutics hauls in $53 mln

Rani Therapeutics, a developer of a pill designed to replace injectable drug delivery for patients suffering from chronic diseases, has raised $53 million in funding. The investors included GeneScience Pharmaceuticals, Bossa Ventures, Cathay Venture Inc, GV, Alphabet Inc's investment arm, Novartis, …

Rani Therapeutics Blogs

Rani nabs $69M Series E for its stab at a robotic pill to replace injectable drugs

The post Rani nabs $69M Series E for its stab at a robotic pill to replace injectable drugs appeared first on Rani Therapeutics.

Converting injectable drugs into pills

The post Converting injectable drugs into pills appeared first on Rani Therapeutics.

Inventor Mir Imran: “I’d like to see the art of innovation taught in K-12. If we teach everyone to innovate, everyone will be an innovator, regardless of their profession.”

The post Inventor Mir Imran: “I’d like to see the art of innovation taught in K-12. If we teach everyone to innovate, everyone will be an innovator, regardless of their profession.” appeared first on Rani Therapeutics.

Rani Therapeutics Frequently Asked Questions

  • When was Rani Therapeutics founded?

    Rani Therapeutics was founded in 2012.

  • Who are Rani Therapeutics key executives?

    Rani Therapeutics's key executives are Mir Imran, Mir Hashim and Svai Sanford.

  • Who are Rani Therapeutics competitors?

    Competitors of Rani Therapeutics include Principia BioPharma, Oramed Pharmaceuticals and Athersys.

  • Where is Rani Therapeutics headquarters?

    Rani Therapeutics headquarters is located at 2051 Ringwood Ave, San Jose.

  • Where are Rani Therapeutics offices?

    Rani Therapeutics has an office in San Jose.

  • How many offices does Rani Therapeutics have?

    Rani Therapeutics has 1 office.